BChE-IN-8 (compound 20) is an orally active butyrylcholinesterase (BChE) inhibitor that crosses the blood-brain barrier, targeting eqBChE (IC50: 0.15 nM) and hBChE (IC50: 45.2 nM). It is used in Alzheimers disease (AD) research for its neuroprotective and cognitive improvement effects, affecting the cholinergic system, Abeta aggregation, and neuropeptide levels.
Molekulargewicht:
438.24
CAS Nummer:
[2653349-78-9]
Formel:
C18H12BrN7O2
Target-Kategorie:
Others|||Beta Amyloid
T62504
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten